What is the ticker symbol for EQRx?

EQRx trades under the ticker EQRX on NASDAQ.

What sector does EQRx operate in?

EQRx is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze EQRX in a portfolio?

PortView shows EQRX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

EQRx (EQRX) Stock Analysis

NASDAQHealthcareBiotechnology

$2.34-2.09%

1-year price historyRange $1.61 – $5.45

52-week range$2.34

$1.58$4.75

What EQRx does

EQRx, Inc. is a U.S.-based pharmaceutical firm dedicated to innovating therapies, predominantly for oncological (cancer) and immune-inflammatory conditions. The company's late-stage pipeline features two promising drug candidates in Phase III clinical trials: Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor specifically for patients with EGFR-mutated non-small cell lung cancer (NSCLC), and Sugemalimab, an anti-programmed death-ligand 1 antibody aimed at treating Stage III and Stage IV NSCLC. Its broader developmental portfolio encompasses a range of additional clinical and pre-clinical assets. This portfolio includes Lerociclib, a small molecule cyclin-dependent kinase 4/6 inhibitor in Phase II trials for metastatic breast cancer; EQ176, an anti-programmed death-1 antibody undergoing Phase III development for primary liver cancer; and EQ121, a selective janus kinase-1 inhibitor currently in various Phase I studies. Established in 2019, EQRx maintains its corporate headquarters in Cambridge, Massachusetts.

Key metrics

Market cap

$1.14B

P/E (TTM)

-4.25

EPS (TTM)

$-0.55

Beta

0.63

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$2.25

200-day avg

$2.05

52-week high

$4.75

52-week low

$1.58

CEO

Melanie I. Nallicheri

ETFs linked to EQRX

Broad-market and Healthcare sector ETFs an investor holding EQRx is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how EQRX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze EQRX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for EQRx?: EQRx trades under the ticker EQRX on NASDAQ.
Which exchange is EQRX listed on?: EQRX is listed on NASDAQ.
What sector does EQRx operate in?: EQRx is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze EQRX in a portfolio?: PortView shows EQRX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.